Metabolic & Cellular Support Peptide Telehealth
Physician-guided evaluation for therapies studied in metabolic signaling and cellular energy pathways.
$99 Consultation | $300 for Peptides if prescribed
Understanding Metabolic & Cellular Support Therapies
Metabolic-support peptides and related therapies are studied for their roles in cellular energy production and metabolic signaling pathways.





Through telehealth, licensed providers evaluate whether these therapies may be appropriate based on medical history and clinical judgment.
Compounded medications are not FDA-approved for the diagnosis, treatment, cure, or prevention of disease.
Therapies We Evaluate For
All therapies require physician evaluation and are prescribed only when clinically appropriate.
Telehealth evaluation determines appropriateness based on individual factors.
Specific therapies are determined during consultation based on clinical appropriateness.
Who Typically Explores Metabolic Peptide Telehealth?
- Maintain active lifestyles
- Focus on performance and recovery
- Experience persistent fatigue despite lifestyle efforts
- Seek structured physician-guided oversight
- Prefer regulated pharmacy fulfillment
Appropriateness is determined only after consultation.
How It Works
You’ll begin with a brief virtual consultation with a licensed medical provider, who will review your medical history and determine whether this therapy may be appropriate for you.
If treatment is recommended, your prescription is sent to a licensed U.S. compounding pharmacy and shipped directly to your home, typically within 3–7 business days.
Consultation Cost
The total cost is $99 for consultation. Peptides are additional.


If a peptide therapy is not clinically appropriate, there is no charge for the visit.
- All therapies are prescribed only when clinically appropriate and based on physician evaluation.
Medical & Regulatory Considerations
Metabolic-support therapies offered through telehealth may involve compounded formulations.
Compounded medications are not FDA-approved and may have limited long-term safety data.
Some therapies discussed in metabolic optimization contexts may be investigational in nature.
All prescribing decisions are made by licensed medical providers based on clinical evaluation.
Statements on this website have not been evaluated by the FDA.
Individual results vary.
- Peptide Disclaimer
- The peptide therapies discussed on this website are compounded medications prescribed by licensed medical providers when clinically appropriate. Many compounded peptides, including but not limited to BPC-157, TB-500, CJC-1295, Ipamorelin, GHK-Cu, MOTS-C, Selank, Semax, and similar therapies, have not been approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of disease.
- Information provided on this website is intended for educational and informational purposes only and should not be interpreted as medical advice, efficacy claims, or guarantees of outcome. Discussions regarding peptides may reference preclinical, investigational, anecdotal, or emerging research, including animal studies, laboratory data, and limited human experience. Human clinical evidence for many peptide therapies remains limited.
- Statements on this website have not been evaluated by the FDA. Individual results may vary. No claims are made regarding the safety, effectiveness, or superiority of any compounded peptide therapy.
- All treatment decisions are made solely at the discretion of a licensed healthcare provider after review of a patient’s medical history, medications, contraindications, and clinical appropriateness. Certain therapies may not be appropriate for individuals with specific medical conditions, including but not limited to cancer, cardiovascular disease, endocrine disorders, pregnancy, or other health concerns.
- Compounded medications are prepared by licensed compounding pharmacies and are not FDA-approved products. Patients should discuss all risks, benefits, alternatives, and uncertainties with their healthcare provider before beginning treatment.
Frequently Asked Questions
Compounded NAD+ therapies are not FDA-approved for the diagnosis, treatment, cure, or prevention of disease.
NAD+ is studied for its role in cellular energy metabolism. Individual experiences vary and depend on clinical factors.
No therapies are marketed as anti-aging treatments. All therapies are prescribed based on clinical appropriateness.
No. Prescriptions require physician evaluation and approval.
Interested in Structured Metabolic Support?
Schedule your $99 physician consultation today.